James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

3 Reasons Why I Bought AT&T Inc. (T) Stock

AT&T stock hasn't been terribly rewarding over the course of the past year or so, but this is a long game, and value wins in the end.

Kroger Co (KR) Is Getting Desperate

Before you buy KR stock while it looks undervalued, you should consider some of the things KR is doing that look more desperate than creative.

Snap Inc (SNAP) Stock Continues to Baffle the Haters

SNAP stock is a lousy investment, but Snapchat has unveiled a couple of key psychological principles we should all take note of.

Costco Wholesale Corporation Slides on “Just Good” Earnings

Costco's Q4 earnings would be enviable to owners of any other retailer's stock, but COST stock owners have been a little bit spoiled.

Valeant Pharmaceuticals (VRX) Stock Begs Just One Key Question

VRX stock may be on the verge of a technical surge, but if any rally is going to last, VRX will have to answer this question first.